Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor

King Faisal Specialist Hospital & Research Center350 enrolled

Overview

Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantation program for pts w/AML in 1st \& 2nd complete remission w/no HLA matched related donor

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

350

Conditions

Leukemia, Monocytic, Acute

Interventions

Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantationDRUG

Autologous PBSCT

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with AML in 1st \& 2nd complete remission w/no HLA matched related donor

Locations (1)

KFSH&RC

Riyadh, Saudi Arabia

Outcomes

Primary Outcomes

Efficacy

Time frame: 2009-2015

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.